17,245 Shares in USANA Health Sciences, Inc. (NYSE:USNA) Acquired by Dark Forest Capital Management LP

Dark Forest Capital Management LP purchased a new position in USANA Health Sciences, Inc. (NYSE:USNA) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 17,245 shares of the company’s stock, valued at approximately $619,000.

Several other large investors also recently made changes to their positions in USNA. Hsbc Holdings PLC bought a new stake in USANA Health Sciences during the 4th quarter valued at $282,000. Dimensional Fund Advisors LP increased its position in shares of USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after acquiring an additional 55,059 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of USANA Health Sciences in the 4th quarter worth about $618,000. XTX Topco Ltd bought a new position in USANA Health Sciences in the 4th quarter valued at about $231,000. Finally, Barclays PLC lifted its position in USANA Health Sciences by 12.0% in the 4th quarter. Barclays PLC now owns 31,067 shares of the company’s stock valued at $1,116,000 after acquiring an additional 3,330 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Stock Performance

NYSE:USNA opened at $27.07 on Friday. USANA Health Sciences, Inc. has a 52 week low of $23.10 and a 52 week high of $49.78. The firm has a 50-day moving average price of $27.85 and a two-hundred day moving average price of $33.21. The firm has a market cap of $510.54 million, a price-to-earnings ratio of 9.57, a price-to-earnings-growth ratio of 0.93 and a beta of 1.00.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, April 22nd. The company reported $0.73 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.03. The company had revenue of $249.54 million during the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period last year, the business posted $0.86 earnings per share. As a group, sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have commented on USNA. DA Davidson decreased their price objective on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday, February 27th. Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. Finally, StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th.

Insider Activity

In related news, insider David Mulham Mulham sold 3,234 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $32.98, for a total value of $106,657.32. Following the transaction, the insider now owns 12,775 shares in the company, valued at approximately $421,319.50. This represents a 20.20 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jim Brown sold 5,000 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the sale, the chief executive officer now directly owns 15,716 shares of the company’s stock, valued at $463,150.52. This represents a 24.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,920 shares of company stock valued at $500,285 in the last ninety days. 0.63% of the stock is currently owned by insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.